Business
Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering
Source: Mesa Laboratories, Inc. – June 16, 2020 11:30 AM ET Lakewood, Colo., June 16, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa
About this update from Mesa Laboratories, Inc.
[{"type":"text","content":"Source: Mesa Laboratories, Inc. – June 16, 2020 11:30 AM ET\n Lakewood, Colo., June 16, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced that the underwriters for its previously announced public offering of common stock have fully exercised their option to purchase 90,000 additional shares of Mesa Labs common stock. The issuance of the additional shares will result in additional gross proceeds of approximately $20.3 million to Mesa Labs, and gross proceeds for the offering as a whole of approximately $155.3 million, in each case before deducting underwriting discounts and commissions and other estimated offering expenses. The initial closing of the offering occurred on June 12, 2020, and the closing of the issuance of the additional shares occurred on June 16, 2020. Mesa Labs intends to use the net proceeds from the offering for general corporate purposes, which may include acquisitions. Jefferies LLC, J.P. Morgan and Evercore Group L.L.C. acted as joint book-running managers for the offering. The offering was effected pursuant to Mesa Labs’ shelf registration statement (including a base prospectus), which Mesa Labs filed with the Securities and Exchange Commission (the “SEC”). The final prospectus supplement related to the offering was filed with SEC. Copies of the final prospectus supplement, including the base prospectus, may be freely obtained by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies may be obtained from Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone at (877) 821-7388, or by email at [email protected], or from J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204, or by email at [email protected], or from Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 35th Floor, New York, NY 10055, or by telephone at (888) 474-0200, or by email at [email protected]. This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any offer or sale of, the shares in any state or jurisdiction in which the offer, solicitation, or sale of the shares would be unlawful pri...